Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
The DOI matches its Crossref record; 448 of the 448 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 448
Wolff, K., Tsapakis, E. M., Winstock, A. R., Hartley, D., Holt, D., Forsling, M. L., & Aitchison, K. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061514 · Cited by 108 · cited 1×
“MDMA intake by humans, in typical oral recreational doses ranging from 50 to 150 mg, has been shown to increase plasma levels of adrenocorticotropic hormone, cortisol, prolactin, oxytocin, arginine, and vasopressin, with a decrease in plasma Na concentrations [56, 225, 226].”
BackgroundShankaran, M., & Gudelsky, G. A. (1999) · Psychopharmacology · doi:10.1007/s002130051143 · Cited by 108
Shankaran, M., Yamamoto, B. K., & Gudelsky, G. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00728-1 · Cited by 106
Quednow, B. B., Jessen, F., Kühn, K.-U., Maier, W., Daum, I., & Wagner, M. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061200 · Cited by 106
Sabol, K. E., Lew, R., Richards, J. B., Vosmer, G. L., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12371-9 · Cited by 106
Oxidation of serotonin by superoxide radical: Implications to neurodegenerative brain disorders
Wrona, M. Z., & Dryhurst, G. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970185w · Cited by 105
Colado, M. I., & Green, A. R. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00298-y · Cited by 105
Segura, M., Ortuño, J., Farré, M., McLure, J. A., Pujadas, M., Pizarro, N., Llebaria, A., Joglar, J., Roset, P. N., Segura, J., et al. (2001) · Chemical Research in Toxicology · doi:10.1021/tx010051p · Cited by 104
Sanchez, V, Camarero, J., Esteban, B., Peter, M. J., Green, A. R., & Colado, M. I. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704230 · Cited by 103
Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning
Sprague, J. E., Preston, A. S., Leifheit, M., & Woodside, B. L. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00092-1 · Cited by 101
Impact of psychostimulants on vesicular monoamine transporter function
Fleckenstein, A. E., & Hanson, G. R. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.077 · Cited by 101
Capela, J. P., Ruscher, K., Lautenschlager, M., Freyer, D., Dirnagl, U., Gaio, R., Bastos, M. D. L., Meisel, A., & Carvalho, F. D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.007 · Cited by 101
Self-citationBehavioural analysis of the acute and chronic effects of MDMA treatment in the rat
Marston, H. M., Reid, M., Lawrence, J. A., Olverman, H. J., & Butcher, S. P. (1999) · Psychopharmacology · doi:10.1007/s002130050978 · Cited by 101
O’Shea, E., Esteban, B. M., Camarero, J., Green, A. R., & Colado, M. I. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00106-4 · Cited by 101
Lew, R., Sabol, K. E., Chou, C., Vosmer, G. L., Richards, J. B., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12372-0 · Cited by 101
Schenk, S., Hely, L. S., Lake, B., Daniela, E. J. K., Gittings, D., & Mash, D. C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05932.x · Cited by 100
Wang, X., Baumann, M. H., Xu, H., & Rothman, R. B. (2004) · Synapse · doi:10.1002/syn.20058 · Cited by 100
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2008) · Cited by 100
Jiménez, A., Jordà, E. G., Verdaguer, E., Pubill, D., Sureda, F. X., Canudas, A. M., Escubedo, E., Camarasa, J., Camins, A., & Pallàs, M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.017 · Cited by 98
Shankaran, M., Yamamoto, B. K., & Gudelsky, G. A. (2001) · Synapse · Cited by 98
Doblin, R. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399952 · Cited by 98
Schmued, L. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02563-0 · Cited by 98
Can psychedelics have a role in psychiatry once again?
Sessa, B. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.6.457 · Cited by 98
Cognition in Novice Ecstasy Users With Minimal Exposure to Other Drugs: A Prospective Cohort Study
Schilt, T., de Win, M. M. L., Koeter, M., Jager, G., Korf, D. J., van den Brink, W., & Schmand, B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.728 · Cited by 96
MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
Heydari, A., Yeo, K. R., Lennard, M. S., Ellis, S. W., Tucker, G. T., & Rostami‐Hodjegan, A. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001180 · Cited by 96
Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users
Dafters, R. I., Hoshi, R., & Talbot, A. C. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1561-4 · Cited by 96
Miller, D. B., & O'Callaghan, J. P. (1995) · Molecular Neurobiology · doi:10.1007/bf02740694 · Cited by 95
O’Shea, E., Escobedo, I., Orío, L., Sánchez, V., Navarro, M. A., Green, A. R., & Colado, M. I. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300673 · Cited by 95
Serotonin–GABA interactions modulate MDMA‐induced mesolimbic dopamine release
Bankson, M. G., & Yamamoto, B. K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02763.x · Cited by 95
Sprague, J. E., Banks, M. L., Cook, V. J., & Mills, E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044982 · Cited by 95
An Exploration of the History and Controversies Surrounding MDMA and MDA
Pentney, A. R. (2001) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2001.10400568 · Cited by 94
Lin, H., Burden, P. M., Christie, M. J., & Johnston, G. A. R. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00191-9 · Cited by 94
Nomenclature for human DPYD alleles
McLeod, H. L., Collie-Duguid, E. S. R., Vreken, P., Johnson, M. R., Wei, X., Sapone, A., Diasio, R. B., Fernández‐Salguero, P. M., van Kuilenberg, A. B. P., Gennip, A. H., et al. (1998) · Pharmacogenetics · doi:10.1097/00008571-199812000-00001 · Cited by 94
Neurotoxic Indoleamines and Monoamine Neurons
Baumgarten, H. G., & Björklund, A. (1976) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.16.040176.000533 · Cited by 93
Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine
Schmidt, C. J., Black, C. K., & Taylor, V. L. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90245-2 · Cited by 93
Miller, R. T., Lau, S. S., & Monks, T. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00044-7 · Cited by 93
Blessing, W. W., & Seaman, B. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00810-2 · Cited by 93
α-Lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity
Aguirre, N., Barrionuevo, M., Ramírez, M. J., Rı́o, J. D., & Lasheras, B. (1999) · Neuroreport · doi:10.1097/00001756-199911260-00039 · Cited by 92
Trigo, J. M., Renoir, T., Lanfumey, L., Hamon, M., Lesch, K., Robledo, P., & Maldonado, R. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.005 · Cited by 91
Alves, E. A., BINIENDA, Z. K., Carvalho, F. D., Alves, C. J., Fernandes, E. G. R., Bastos, M. D. L., Tavares, M. A., & Summavielle, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.041 · Cited by 91
Self-citationRamamoorthy, Y., Tyndale, R. F., & Sellers, E. M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200108000-00003 · Cited by 91
Long term psychiatric and cognitive effects of MDMA use
McGuire, P. K. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00219-2 · Cited by 90
McNamara, M. G., Kelly, J. P., & Leonard, B. E. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00206-c · Cited by 88
Paris, J. M., & Cunningham, K. A. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90237-r · Cited by 88
Costa, V. M., Silva, R. V. D. S., Ferreira, L. M., Branco, P. S., Carvalho, F. D., Bastos, M. D. L., Carvalho, R. A., Carvalho, M. C., & Remião, F. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7000916 · Cited by 87
Self-citationEcstasy induces apoptosis via 5-HT2A-receptor stimulation in cortical neurons
Capela, J. P., Fernandes, E. G. R., Remião, F., Bastos, M. D. L., Meisel, A., & Carvalho, F. D. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.04.005 · Cited by 87
Self-citationParrott, A. C. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0703-5 · Cited by 87 · cited 1×
“However, there are many drawbacks for the medical use of MDMA, as recently reviewed by Parrot [12].”
BackgroundLoss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines
Xie, T., Tong, L., McLane, M. W., Hatzidimitriou, G., Yuan, J., McCann, U. D., & Ricaurte, G. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301031 · Cited by 86
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
Alves, E., Summavielle, T., Alves, C. J., GOMES‐DA‐SILVA, J., Barata, J. C., Fernandes, E. G. R., Bastos, M. D. L., Ferreira, M. A., & Carvalho, F. D. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2645-07.2007 · Cited by 86
Self-citationArai, K., Ikegaya, Y., Nakatani, Y., Kudo, I., Nishiyama, N., & Matsuki, N. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01623.x · Cited by 86
Neurotoxicity of Ecstasy Metabolites in Rat Cortical Neurons, and Influence of Hyperthermia
Capela, J. P., Meisel, A., Abreu, A. R., Branco, P. S., Ferreira, L. M., Lobo, A. M., Remião, F., Bastos, M. L., & Carvalho, F. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092577 · Cited by 85
Self-citationHo, Y., Pawlak, C. R., Guo, L., & Schwarting, R. K. W. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00220-1 · Cited by 84
Daumann, J., Fischermann, T., Heekeren, K., Henke, K., Thron, A. K., & Gouzoulis‐Mayfrank, E. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2002-8 · Cited by 84
Gamma, A., Buck, A., Berthold, T., & Vollenweider, F. X. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00012 · Cited by 84
Blessing, W. W., Seaman, B. W., Pedersen, N. P., & Ootsuka, Y. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06385.2003 · Cited by 83
Bull, E., Hutson, P. H., & Fone, K. C. F. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.004 · Cited by 83
GREER, G., & Strassman, R. J. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1391 · Cited by 82
Carvalho, M. X. E. R., HAWKSWORTH, G. M., Milhazes, N., Borges, F., Monks, T. J., Fernandes, E. G. R., Carvalho, F. X. E. L., & Bastos, M. D. L. (2002) · Archives of Toxicology · doi:10.1007/s00204-002-0381-3 · Cited by 82
Self-citationHewitt, K. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90134-1 · Cited by 81
Identification of Stereoselective Transporters for S-Nitroso-L-cysteine
Li, S., & Whorton, A. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413164200 · Cited by 81
Azmitia, E. C., Murphy, R. B., & Whitaker‐Azmitia, P. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90732-q · Cited by 81
Carvalho, M. C., Remião, F., Milhazes, N., Borges, F., Fernandes, E. G. R., Carvalho, F. D., & Bastos, M. D. L. (2004) · Toxicology · doi:10.1016/j.tox.2004.03.016 · Cited by 81
Self-citationRoiser, J. P., Cook, L. J., Cooper, J. D., Rubinsztein, D. C., & Sahakian, B. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.609 · Cited by 81
Stone, D. M., Johnson, M., Hanson, G. R., & Gibb, J. W. (1989) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(89)90048-5 · Cited by 80
Sprague, J. E., Moze, P., Caden, D., Rusyniak, D. E., Holmes, C. S., Goldstein, D. S., & Mills, E. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000165969.29002.70 · Cited by 80
Morley, K. C., Arnold, J. C., & McGregor, I. S. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.009 · Cited by 79 · cited 1×
“MDMAinduced generalized anxiety to rats, as measured by the emergence test, seems unlikely to involve the 5-HT1A, 5HT1B or 5-HT2A, 5-HT2B or 5-HT2C receptors, since antagonists targeted to these receptors did not prevent this effect [180].”
BackgroundOrio, L., O'Shea, E., Sanchez, V., Pradillo, J. M., Escobedo, I., Camarero, J., Moro, M. A., Green, A. R., & Colado, M. I. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02443.x · Cited by 79
Colado, M. I., Granados, R., O’Shea, E., Esteban, B. M., & Green, A. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701859 · Cited by 79
Able, J. A., Gudelsky, G. A., Vorhees, C. V., & Williams, M. T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.006 · Cited by 78
Aguirre, N., Ballaz, S., Lasheras, B., & Rı́o, J. D. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00062-4 · Cited by 78
Metabolism Is Required for the Expression of Ecstasy-Induced Cardiotoxicity in Vitro
Carvalho, M. C., Remião, F., Milhazes, N., Borges, F., Fernandes, E. G. R., Monteiro, M. D. C., Gonçalves, M. J., Seabra, V., Amado, F. M. L., Carvalho, F. D., et al. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049960f · Cited by 78
Self-citationPizarro, N., Farré, M., Pujadas, M., Peiró, A., Roset, P., Joglar, J., & de la Torre, R. (2004) · Drug Metabolism And Disposition · doi:10.1016/s0090-9556(24)02984-2 · Cited by 78
McLeod, H. L., Fang, L., Luo, X., Scott, E. P., & Evans, W. E. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22361-8 · Cited by 78
White, S. R., Duffy, P., & Kalivas, P. W. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90313-1 · Cited by 77
Kolbrich, E. A., Goodwin, R. S., Gorelick, D. A., Hayes, R. J., Stein, E. A., & Huestis, M. A. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31817ef470 · Cited by 77
Shen, X.-M., & Dryhurst, G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960008f · Cited by 76
Stone, D. M., Johnson, M., Hanson, G. R., & Gibb, J. W. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90173-7 · Cited by 75
Contribution of Cytochrome P450 2D6 to 3,4-Methylenedioxymethamphetamine Disposition in Humans
Segura, M., Farré, M., Pichini, S., Peiró, A., Roset, P., Ramírez, A., Ortuño, J., Pacifici, R., Zuccaro, P., Segura, J., et al. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544060-00006 · Cited by 75
Nash, J. F., Roth, B. L., Brodkin, J. D., Nichols, D. E., & Gudelsky, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90057-4 · Cited by 75
Fatal uncertainty: death-rate from use of ecstasy or heroin
Gore, S. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02729-4 · Cited by 74
Rapid mtDNA deletion by oxidants in rat liver mitochondria after hemin exposure
Suliman, H. B., Carraway, M. S., Velsor, L. W., Day, B. J., Ghio, A. J., & Piantadosi, C. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00797-3 · Cited by 74
Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose
García-Repetto, R., Moreno, E., Soriano, T., Jurado, C., Giménez, M. P., & Menéndez‐González, M. (2003) · Forensic Science International · doi:10.1016/s0379-0738(03)00179-8 · Cited by 74
Implications of pharmacogenetics for individualizing drug treatment and for study design
Meisel, C., Gerloff, T., Kirchheiner, J., Mrozikiewicz, P. M., Niewiński, P., Brockmöller, J., & Roots, I. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0417-4 · Cited by 73
Badon, L. A., Hicks, A. R., Lord, K. C., Ogden, B. A., Meleg-Smith, S., & Varner, K. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.898 · Cited by 73
Green, A. R., O’Shea, E., Saadat, K. S., Elliott, J. M., & Colado, M. I. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706318 · Cited by 72
Functional MRI study of working memory in MDMA users
Moeller, F. G., Steinberg, J. L., Dougherty, D. M., Narayana, P. A., Kramer, L. A., & Renshaw, P. F. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1908-5 · Cited by 72
Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs
Itzhak, Y., & Ali, S. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.004 · Cited by 71
Ramos, M., Goñi‐Allo, B., & Aguirre, N. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300735 · Cited by 71
Carvalho, M. C., Carvalho, F. D., Remião, F., Pereira, M. D. L., das Neves, R. P., & Bastos, M. D. L. (2002) · Archives of Toxicology · doi:10.1007/s00204-002-0324-z · Cited by 71
Self-citationde Win, M. M. L., Schilt, T., Reneman, L., Vervaeke, H., Jager, G., Dijkink, S., Booij, J., & van den Brink, W. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063275 · Cited by 71
Effect of 3,4-Methylenedioxymethamphetamine (MDMA) on Hippocampal Dopamine and Serotonin
Shankaran, M., & Gudelsky, G. A. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00103-8 · Cited by 71
Wang, X., Baumann, M. H., Xu, H., Morales, M., & Rothman, R. B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088476 · Cited by 70
King, L. A. (2007) · Royal Society of Chemistry paperbacks · doi:10.1039/9781847552112 · Cited by 70
Ramamoorthy, Y., Yu, A.-M., Suh, N., Haining, R., Tyndale, R., & Sellers, E. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01028-6 · Cited by 69
Shankaran, M., Yamamoto, B. K., & Gudelsky, G. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722516.x · Cited by 69
Escobedo, I., O’Shea, E., Orío, L., Sánchez, V., Segura, M., de la Torre, R., Farré, M., Green, A. R., & Colado, M. I. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706071 · Cited by 68
Connor, T. J., McNamara, M. G., Finn, D. P., Currid, A., O'Malley, M., Redmond, A., Kelly, J. P., & Leonard, B. E. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(97)00084-2 · Cited by 68
Koprich, J. B., Chen, E., Kanaan, N. M., Campbell, N. G., Kordower, J. H., & Lipton, J. W. (2003) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(03)00091-6 · Cited by 68
Mechan, A., Yuan, J., Hatzidimitriou, G., Irvine, R. J., McCann, U. D., & Ricaurte, G. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300808 · Cited by 67
Sánchez, V., O’Shea, E., Saadat, K. S., Elliott, J. M., Colado, M. I., & Green, A. R. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800312 · Cited by 67
Piper, B. J., Fraiman, J., & Meyer, J. S. (2005) · Developmental Psychobiology · doi:10.1002/dev.20085 · Cited by 67
Lile, J. A., Ross, J. T., & Nader, M. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.10.006 · Cited by 67
Kuhn, D. M., & Arthur, R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07245.1997 · Cited by 66
MDMA (‘ecstasy’) enhances basal acetylcholine release in brain slices of the rat striatum
Fischer, H. S., Zernig, G., Schatz, D. S., Humpel, C., & Saria, A. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00004.x · Cited by 66
Darvesh, A. S., Yamamoto, B. K., & Gudelsky, G. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074849 · Cited by 66
Dafters, R. I., & Lynch, E. (1998) · Psychopharmacology · doi:10.1007/s002130050664 · Cited by 66
Acute medical problems due to Ecstasy use
Kunz, I. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11231 · Cited by 65
Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans.
Pacifici, R., Zuccaro, P., Farré, M., Pichini, S., di Carlo, S., Roset, P., Ortuño, J., Pujadas, M., Bacosi, A., Menoyo, E., et al. (2001) · Life Science · doi:10.1016/s0024-3205(01)01373-x · Cited by 65
Bexis, S., & Docherty, J. R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706688 · Cited by 64
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.
Baumann, M., Clark, R. D., Franken, F. H., Rutter, J. J., & Rothman, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.007 · Cited by 64
McNamara, R., Kerans, A., O’Neill, B. V., & Harkin, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.006 · Cited by 64
Mechan, A. O., O’Shea, E., Elliott, M., Colado, M., & Green, R. A. (2001) · Psychopharmacology · doi:10.1007/s002130100735 · Cited by 64
Daumann, J., Fischermann, T., Heekeren, K., Thron, A. K., & Gouzoulis‐Mayfrank, E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.011 · Cited by 63
Check, E. (2004) · Nature · doi:10.1038/429126a · Cited by 62
Miller, R. T., Lau, S. S., & Monks, T. J. (1996) · Chemical Research in Toxicology · doi:10.1021/tx9501546 · Cited by 62
Armstrong, B. D., & Noguchi, K. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.06.003 · Cited by 61
Plasma Drug Concentrations and Physiological Measures in ‘Dance Party’ Participants
Irvine, R. J., Keane, M. J., FELGATE, P. D., McCann, U. D., Callaghan, P. D., & White, J. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300896 · Cited by 60
Johnson, M., Letter, A. A., Merchant, K., Hanson, G. R., & Gibb, J. W. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24573-6 · Cited by 60
Aguirre, N., Barrionuevo, M., Lasheras, B., & Río, J. D. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37706-7 · Cited by 59
Schmidt, C. J., Abbate, G. M., Black, C. K., & Taylor, V. L. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22923-8 · Cited by 59
O’Shea, E., Orío, L., Escobedo, I., Sánchez, V., Camarero, J., Green, A. R., & Colado, M. I. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706783 · Cited by 58
Busceti, C. L., Biagioni, F., Riozzi, B., Battaglia, G., Storto, M., Cinque, C., Molinaro, G., Gradini, R., Caricasole, A., Canudas, A. M., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0159-08.2008 · Cited by 58
Abekawa, T., Ito, K., Nakagawa, S., Nakato, Y., & Koyama, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.488 · Cited by 58
Renoir, T., Païzanis, E., Yacoubi, M. E., Saurini, F., Hanoun, N., Melfort, M., Lesch, K., Hamon, M., & Lanfumey, L. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009048 · Cited by 58
Jager, G., de Win, M. M. L., Vervaeke, H., Schilt, T., Kahn, R. S., van den Brink, W., van Ree, J. M., & Ramsey, N. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0792-1 · Cited by 57
Sex differences in the neurochemical and functional effects of MDMA in Sprague–Dawley rats
Walker, Q. D., Williams, C. N., Jotwani, R. P., Waller, S. T., Francis, R., & Kuhn, C. M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0531-z · Cited by 57
Gudelsky, G. A. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271253 · Cited by 57
Goñi‐Allo, B., Mathúna, B. Ó., Segura, M., Puerta, E., Lasheras, B., de la Torre, R., & Aguirre, N. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1027-1 · Cited by 56
Koprich, J. B., Campbell, N. G., & Lipton, J. W. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(03)00219-0 · Cited by 56
Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents
Chipana, C., TORRES, I., Camarasa, J., Pubill, D., & Escubedo, E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.003 · Cited by 56
Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicity
Carmo, H., Brulport, M., Hermes, M., Oesch, F., Silva, R., Ferreira, L., Branco, P., de Boer, D., Remião, F., Carvalho, F., et al. (2006) · Pharmacogenetics & Genomics · doi:10.1097/01.fpc.0000230419.05221.fc · Cited by 55
Self-citationde la Torre, R., Ortuño, J., Más, M., Farré, M., & Segura, J. (1999) · The Lancet · doi:10.1016/s0140-6736(05)75653-1 · Cited by 55
Ali, S. F., Newport, G. D., Scallet, A. C., BINIENDA, Z. K., Ferguson, S. A., Bailey, J. R., Paule, M. G., & SLIKKERJR, W. (1993) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(93)90067-x · Cited by 55
Hernández‐Rabaza, V., Domínguez‐Escribá, L., Barcia, J. A., Rosel, J., Romero, F. J., García‐Verdugo, J. M., & Canales, J. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.019 · Cited by 55
Fornai, F., Lenzi, P., Frenzilli, G., Gesi, M., Ferrucci, M., Lazzeri, G., Biagioni, F., Nigro, M., Falleni, A., Giusiani, M., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1708-3 · Cited by 55
Lavelle, A., Honner, V., & Docherty, J. R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702875 · Cited by 54
Bull, E. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00407-0 · Cited by 54
Cardiovascular and sympathetic responses and reflex changes elicited by MDMA
O'Cain, P., Hletko, S. B., Ogden, B. A., & Varner, K. J. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00235-3 · Cited by 54
Pontes, H., Duarte, J. A., de Pinho, P. G., Soares, M. E., Fernandes, E. G. R., Dinis‐Oliveira, R. J., Sousa, C., Silva, R. V. D. S., Carmo, H., Casal, S. I. P., et al. (2008) · Toxicology · doi:10.1016/j.tox.2008.07.064 · Cited by 53
Self-citationSprague, J. E., Brutcher, R. E., Mills, E., Caden, D., & Rusyniak, D. E. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705823 · Cited by 53
Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies
Freimuth, R. R., Eckloff, B. W., Wieben, E. D., & Weinshilboum, R. M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200112000-00002 · Cited by 52
Jones, D. C., Lau, S. S., & Monks, T. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069260 · Cited by 52
Nitric Oxide and the Neurotoxic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine
Taraska, T., & Finnegan, K. T. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36495-x · Cited by 52
Ádori, C., Andó, R. D., Kovács, G. G., & Bagdy, G. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20994 · Cited by 51
Effect of the d electrons on phase transitions in transition-metal sesquioxides
Umemoto, K., & Wentzcovitch, R. M. M. (2010) · Physics and Chemistry of Minerals · doi:10.1007/s00269-010-0412-1 · Cited by 51
Navarro, J. F., & Maldonado, E. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00250-6 · Cited by 51
Baker, L. E., Broadbent, J., Michael, E. K., Matthews, P. K., Metosh, C. A., Saunders, R. B., West, W. B., & Appel, J. B. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199504000-00007 · Cited by 51
Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2
Yamamoto, Y., Tasaki, T., Nakamura, A., Iwata, H., Kazusaka, A., Gonzalez, F. J., & Fujita, S. (1998) · Pharmacogenetics · doi:10.1097/00008571-199802000-00010 · Cited by 51
Delaforge, M., Jaouen, M., & Bouillé, G. (1999) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(99)00007-1 · Cited by 51
Yuan, J., Cord, B. J., McCann, U. D., Callahan, B. T., & Ricaurte, G. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00758.x · Cited by 51
Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain
Izco, M., Orío, L., O’Shea, E., & Colado, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0602-1 · Cited by 50
Brain concentrations of d-MDMA are increased after stress
Johnson, E. A., O'Callaghan, J. P., & Miller, D. B. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1740-3 · Cited by 50
Farfel, G. M., Vosmer, G. L., & Seiden, L. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91460-v · Cited by 49
Neurotoxic effects of MDMA (“ecstasy”) administration to neonatal rats
Meyer, J. S., Grande, M., Johnson, K. M., & Ali, S. F. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.04.007 · Cited by 49
Assessment of the MDA and MDMA Optical Isomers in a Stimulant-Hallucinogen Discrimination
Baker, L. E., & Taylor, M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00334-6 · Cited by 49
Warren, M. W., Larner, S. F., Kobeissy, F. H., Brezing, C., Jeung, J. A., Hayes, R. L., Gold, M. S., & Wang, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0259-9 · Cited by 48
Wichems, C. H., Hollingsworth, C. K., & Bennett, B. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00774-k · Cited by 48
Erives, G. V., Lau, S. S., & Monks, T. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128785 · Cited by 48
Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 48
Touriño, C., Ledent, C. A., Maldonado, R. J., & Valverde, O. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.003 · Cited by 47
Crean, R., Davis, S. A., Huben, S. N. V., Lay, C. C., Katner, S., & Taffe, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.033 · Cited by 47
Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys
Taffe, M. A., Lay, C. C., Huben, S. N. V., Davis, S. A., Crean, R. D., & Katner, S. N. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.09.013 · Cited by 47
Functional consequences of perinatal exposure to3,4‐methylenedioxymethamphetamine in rat brain
Kelly, P. A. T., Ritchie, I. M., Quate, L., McBean, D. E., & Olverman, H. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704961 · Cited by 46
Ootsuka, Y., Nalivaiko, E., & Blessing, W. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.03.058 · Cited by 46
Cohen, M. A., Skelton, M. R., Schaefer, T. L., Gudelsky, G. A., Vorhees, C. V., & Williams, M. T. (2005) · Synapse · doi:10.1002/syn.20166 · Cited by 46
Garcia‐Ratés, S., Camarasa, J., Escubedo, E., & Pubill, D. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.015 · Cited by 45
Huben, S. N. V., Lay, C. C., Crean, R. D., Davis, S. A., Katner, S. N., & Taffe, M. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301078 · Cited by 45
FitzGerald, J., & Reid, J. J. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03738.x · Cited by 44
Connor, T. J., Kelly, J. P., McGee, M., & Leonard, B. E. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00743-8 · Cited by 44
Colussi‐Mas, J., & Schenk, S. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06467.x · Cited by 43
Memantine prevents MDMA-induced neurotoxicity
Chipana, C., Camarasa, J., Pubill, D., & Escubedo, E. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.005 · Cited by 43
Banks, M. L., Sprague, J. E., Kisor, D. F., Czoty, P. W., Nichols, D. E., & Nader, M. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016261 · Cited by 43
CYP2D6 deficiency, a factor in ecstasy related deaths?
Gilhooly, T., & Daly, A. K. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01574.x · Cited by 42
Role of α2A‐adrenoceptors in the effects of MDMA on body temperature in the mouse
Bexis, S., & Docherty, J. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706320 · Cited by 42
Bowyer, J. F., Young, J. F., Slikker, W., Itzak, Y., Mayorga, A. J., Newport, G., Ali, S. F., Frederick, D. L., & Paule, M. (2003) · Neurotoxicology · doi:10.1016/s0161-813x(03)00030-5 · Cited by 42
Restraint as a stressor in mice:
Johnson, E. A., Sharp, D. S., & Miller, D. B. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02601-9 · Cited by 41
Montgomery, T., Buon, C., Eibauer, S., Guiry, P. J., KEENAN, A. K., & McBean, G. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707473 · Cited by 41
Wrona, M. Z., Yang, Z., McAdams, M. L., O'Connor‐Coates, S., & Dryhurst, G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031390.x · Cited by 41
Frenzilli, G., Ferrucci, M., Giorgi, F. S., Blandini, F., Nigro, M., Ruggieri, S. A., Murri, L., Paparelli, A., & Fornai, F. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d518aa · Cited by 41
Cohen, R. S., & Cocores, J. A. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00045-6 · Cited by 40
L-Tyrosine Contributes to (+)-3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletions
Breier, J. M., Bankson, M. G., & Yamamoto, B. K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3353-05.2006 · Cited by 40
MDMA administration to pregnant Sprague–Dawley rats results in its passage to the fetal compartment
Campbell, N. G., Koprich, J. B., Kanaan, N. M., & Lipton, J. W. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.05.006 · Cited by 40
Galineau, L., Belzung, C., Kodas, E., Bodard, S., Guilloteau, D., & Chalon, S. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.10.012 · Cited by 40
McCann, U. D., & Ricaurte, G. A. (1991) · Brain Research · doi:10.1016/0006-8993(91)91297-e · Cited by 40
Kindlundh-Högberg, A. M., Blomqvist, A., Malki, R., & Schiöth, H. B. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-39 · Cited by 40
Zheng, Y., & Laverty, R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00313-8 · Cited by 39
Falk, E. M., Cook, V. J., Nichols, D. E., & Sprague, J. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00728-1 · Cited by 39
Colado, M. I., O’Shea, E., Esteban, B. M., Granados, R., & Green, A. R. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00174-9 · Cited by 38
Williams, M. T., Schaefer, T. L., Ehrman, L. A., Able, J. A., Gudelsky, G. A., Sah, R., & Vorhees, C. V. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.045 · Cited by 37
Gordon, C. J., & Fogelson, L. (1994) · Physiology & Behavior · doi:10.1016/0031-9384(94)90263-1 · Cited by 37
Carmo, H., de Boer, D., Remião, F., Carvalho, F. D., dos Reys, L. A., & Bastos, M. D. L. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.08.026 · Cited by 36
Self-citationCallahan, P. M., & Appel, J. B. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22199-1 · Cited by 36
Slot, A. J., Wise, D. D., Deeley, R. G., Monks, T. J., & Cole, S. P. C. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019661 · Cited by 35
Sumnall, H. R., O’Shea, E., Marsden, C. A., & Cole, J. C. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.02.007 · Cited by 35
Upreti, V. V., & Eddington, N. D. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21045 · Cited by 35
Rowland, N. E., Kalehua, A. N., Li, B.-H., Semple‐Rowland, S. L., & Streit, W. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90057-t · Cited by 35
Macedo, C., Branco, P. S., Ferreira, L. M., Lobo, A. M., Capela, J. P., Fernandes, E. G. R., Bastos, M. D. L., & Carvalho, F. D. (2007) · Eisei kagaku · doi:10.1248/jhs.53.31 · Cited by 35
Self-citationKramer, H. K., Poblete, J. C., & Azmitia, E. C. (1998) · Neuropsychopharmacology · doi:10.1038/sj.npp.1395211 · Cited by 35
Kramer, H. K., Poblete, J. C., & Azmitia, E. C. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00026-2 · Cited by 34
Validity of [123I]β‐CIT SPECT in detecting MDMA‐induced serotonergic neurotoxicity
Reneman, L., Booij, J., Habraken, J. B. A., de Bruin, K. M., Hatzidimitriou, G., den Heeten, G. J., & Ricaurte, G. A. (2002) · Synapse · doi:10.1002/syn.10130 · Cited by 34
Cited by
Parkinson’s disease: animal models and dopaminergic cell vulnerability
Blesa, J., & Przedborski, S. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00155 · Cited by 480
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
Self-citationAmphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
Moratalla, R., Khairnar, A., Simola, N., Granado, N., García-Montes, J. R., Porceddu, P. F., Tizabi, Y., Costa, G., & Morelli, M. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.011 · Cited by 225
“Moreover, DA and 5-HT are metabolized by MAO-B, inducing the formation of superoxide (O2 ) and hydrogen peroxide (H2O2) (Capela et al., 2009).”
BackgroundInfluentialMechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Schenk, S., & Highgate, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15348 · Cited by 48
“(Capela et al., 2009; Colado et al., 2004; Easton & Marsden, 2006).”
Metadata
- Authors
- Capela, J. P., Carmo, H., Remião, F., Bastos, M. L., Meisel, A., & Carvalho, F.
- Venue
- Molecular Neurobiology
- Published
- 2009-04-17
- Volume
- 39
- Issue
- 3
- Pages
- 210-271
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2048841731
- Cited by
- 290
- References
- 448
- FWCI
- 32.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.